Výsledky vyhledávání - Pedroncelli, Alberto M
- Zobrazuji výsledky 1 - 9 z 9
-
1
Pasireotide treatment significantly reduces tumor volume in patients with Cushing’s disease: results from a Phase 3 study Autor Lacroix, André, Gu, Feng, Schopohl, Jochen, Kandra, Albert, Pedroncelli, Alberto M., Jin, Lixian, Pivonello, Rosario
Vydáno 2019Text -
2
Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly Autor Schmid, Herbert A., Brue, Thierry, Colao, Annamaria, Gadelha, Mônica R., Shimon, Ilan, Kapur, Karen, Pedroncelli, Alberto M., Fleseriu, Maria
Vydáno 2016Text -
3
Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study Autor Findling, James W., Fleseriu, Maria, Newell-Price, John, Petersenn, Stephan, Pivonello, Rosario, Kandra, Albert, Pedroncelli, Alberto M., Biller, Beverly M. K.
Vydáno 2016Text -
4
Long-Term Control of Urinary Free Cortisol With Osilodrostat in Patients With Cushing’s Disease: Final Results From the LINC 2 Study Autor Fleseriu, Maria, Biller, Beverly M K, Bertherat, Jerome, Young, Jacques, Arnaldi, Giorgio, O’Connell, Paul, Izquierdo, Miguel, Pedroncelli, Alberto M, Pivonello, Rosario
Vydáno 2021Text -
5
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study Autor Samson, Susan L., Gu, Feng, Feldt-Rasmussen, Ulla, Zhang, Shaoling, Yu, Yerong, Witek, Przemysław, Kalra, Pramila, Pedroncelli, Alberto M., Pultar, Philippe, Jabbour, Nadine, Paul, Michaela, Bolanowski, Marek
Vydáno 2021Text -
6
Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study Autor Colao, Annamaria, Bronstein, Marcello D, Brue, Thierry, De Marinis, Laura, Fleseriu, Maria, Guitelman, Mirtha, Raverot, Gerald, Shimon, Ilan, Fleck, Jürgen, Gupta, Pritam, Pedroncelli, Alberto M, Gadelha, Mônica R
Vydáno 2020Text -
7
Risk factors and management of pasireotide-associated hyperglycemia in acromegaly Autor Gadelha, Mônica R, Gu, Feng, Bronstein, Marcello D, Brue, Thierry C, Fleseriu, Maria, Shimon, Ilan, van der Lely, Aart J, Ravichandran, Shoba, Kandra, Albert, Pedroncelli, Alberto M, Colao, Annamaria A L
Vydáno 2020Text -
8
Osilodrostat Is an Effective and Well-Tolerated Treatment for Cushing’s Disease (CD): Results From a Phase III Study With an Upfront, Randomized, Double-Blind, Placebo-Controlled P... Autor Gadelha, Mônica, Bex, Marie, Feelders, Richard A, Heaney, Anthony P, Auchus, Richard J, Gilis-Januszewska, Aleksandra, Witek, Przemyslaw, Belaya, Zhanna, Liao, Zhihong, Ku, Chih Hao Chen, Carvalho, Davide, Roughton, Michael, Wojna, Judi, Hofstetter, Georg, Pedroncelli, Alberto M, Snyder, Peter J
Vydáno 2021Text -
9
Randomized Trial of Osilodrostat for the Treatment of Cushing Disease Autor Gadelha, Mônica, Bex, Marie, Feelders, Richard A, Heaney, Anthony P, Auchus, Richard J, Gilis-Januszewska, Aleksandra, Witek, Przemyslaw, Belaya, Zhanna, Yu, Yerong, Liao, Zhihong, Ku, Chih Hao Chen, Carvalho, Davide, Roughton, Michael, Wojna, Judi, Pedroncelli, Alberto M, Snyder, Peter J
Vydáno 2022Text